146 related articles for article (PubMed ID: 8144505)
1. Intramolecular charge heterogeneity in purified major histocompatibility class II alpha and beta polypeptide chains.
Nag B; Arimilli S; Koukis B; Rhodes E; Baichwal V; Sharma SD
J Biol Chem; 1994 Apr; 269(13):10061-70. PubMed ID: 8144505
[TBL] [Abstract][Full Text] [Related]
2. The role of N-linked oligosaccharides of MHC class II antigens in T cell stimulation.
Nag B; Wada HG; Arimilli S; Fok K; Passmore D; Sharma SD; McConnell HM
J Immunol Methods; 1994 Jun; 172(1):95-104. PubMed ID: 7515935
[TBL] [Abstract][Full Text] [Related]
3. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
4. Refolding and reconstitution of functionally active complexes of human leukocyte antigen DR2 and myelin basic protein peptide from recombinant alpha and beta polypeptide chains.
Arimilli S; Cardoso C; Mukku P; Baichwal V; Nag B
J Biol Chem; 1995 Jan; 270(2):971-7. PubMed ID: 7529765
[TBL] [Abstract][Full Text] [Related]
5. Divergent and invariant HLA class II beta chain isoelectric points.
Bontrop R; van Miltenburg R; Koning F; Gerrets R; Hyland C; Giphart M
Hum Immunol; 1986 May; 16(1):38-51. PubMed ID: 2423486
[TBL] [Abstract][Full Text] [Related]
6. Functionally active recombinant alpha and beta chain-peptide complexes of human major histocompatibility class II molecules.
Nag B; Arimilli S; Mukku PV; Astafieva I
J Biol Chem; 1996 Apr; 271(17):10413-8. PubMed ID: 8626615
[TBL] [Abstract][Full Text] [Related]
7. Purification and partial amino acid sequence of papain-solubilized class II transplantation antigens.
Wiman K; Claesson L; Rask L; Trägårdh L; Peterson PA
Biochemistry; 1982 Oct; 21(21):5351-8. PubMed ID: 6816270
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility complex (MHC) protein analysis by optimised two-dimensional electrophoretic methods.
Fernandez N; Labeta M; Kurpisz M; Nakatsuji T; Sachs J; Festenstein H
Electrophoresis; 1990 Feb; 11(2):167-74. PubMed ID: 2338072
[TBL] [Abstract][Full Text] [Related]
9. Preparative-scale purification and characterization of MHC class II monomers.
Passmore D; Kopa D; Nag B
J Immunol Methods; 1992 Nov; 155(2):193-200. PubMed ID: 1385534
[TBL] [Abstract][Full Text] [Related]
10. Simplification of two-dimensional gel patterns of HLA class II antigens.
Rust NA; McMichael AJ
Tissue Antigens; 1986 Aug; 28(2):72-83. PubMed ID: 3462963
[TBL] [Abstract][Full Text] [Related]
11. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells.
Nag B; Wada HG; Passmore D; Clark BR; Sharma SD; McConnell HM
J Immunol; 1993 Feb; 150(4):1358-64. PubMed ID: 8432982
[TBL] [Abstract][Full Text] [Related]
12. N-linked oligosaccharides of murine major histocompatibility complex class II molecule. Role in antigenic peptide binding, T cell recognition, and clonal nonresponsiveness.
Nag B; Passmore D; Kendrick T; Bhayani H; Sharma SD
J Biol Chem; 1992 Nov; 267(31):22624-9. PubMed ID: 1385402
[TBL] [Abstract][Full Text] [Related]
13. Separation of four class II molecules from DR2 and DRw6 homozygous B lymphoid cell lines.
Maeda H; Hirata R
Immunogenetics; 1984; 20(6):639-47. PubMed ID: 6392082
[TBL] [Abstract][Full Text] [Related]
14. Analysis of HLA-DR antigen glycosylation by serial lectin affinity chromatography.
Neel D; Giner M; Merlu B; Turmel P; Goussault Y; Charron DJ
Mol Immunol; 1985 Sep; 22(9):1053-9. PubMed ID: 3865052
[TBL] [Abstract][Full Text] [Related]
15. Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
Chang JW; Mechling DE; Bächinger HP; Burrows GG
J Biol Chem; 2001 Jun; 276(26):24170-6. PubMed ID: 11319230
[TBL] [Abstract][Full Text] [Related]
16. Electrophoretic analysis of human HLA-DR antigens from HLA-DR4 homozygous cell lines: correlation between beta-chain diversity and HLA-D.
Nepom BS; Nepom GT; Mickelson E; Antonelli P; Hansen JA
Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6962-6. PubMed ID: 6417660
[TBL] [Abstract][Full Text] [Related]
17. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
[TBL] [Abstract][Full Text] [Related]
18. HLA-DQ structural polymorphism in HLA-DR2 associated HLA-D clusters.
Nakatsuji T; Moriya K; Ando A; Inoko H; Tsuji K
Hum Immunol; 1986 Jun; 16(2):157-62. PubMed ID: 2941397
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis.
Karr RW; Kannapell CC; Stein JA; Fuller TC; Duquesnoy RJ; Rodey GE; Mann DL; Gebel HM; Schwartz BD
J Exp Med; 1982 Aug; 156(2):652-7. PubMed ID: 6980260
[TBL] [Abstract][Full Text] [Related]
20. A biochemical analysis of the secregation of HLA-DR heavy and light chains in a family studied by two-dimensional gel electrophoresis.
Roux-Dosseto M; Rohner C; Birnbaum D; Bourgue F; Rebai N; Mawas C; Goridis C
Ann Immunol (Paris); 1983; 134C(1):55-81. PubMed ID: 6407385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
